Probiotics Compound (Biolosion)

N/A

Report date: 2025/04/20 20:00:03

Base Information

Drug NameProbiotics Compound (Biolosion)
Drug Alias NameN/A
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Transitional Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSun Yat-Sen University
China Registration ClassN/A

Develop Information

Active CompaniesSun Yat-Sen University
Inactive CompaniesN/A
Active IndicationsCarcinoma, Transitional Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A